Literature DB >> 21180624

Depression in epilepsy: mechanisms and therapeutic approach.

Marco Mula1, Bettina Schmitz.   

Abstract

In patients with epilepsy, mood disorders represent a frequent psychiatric comorbidity but they often remain unrecognized and untreated. However, comorbid depression may have a major impact on the quality of life of patients with epilepsy, sometimes even more than the seizures. Among the potential neurobiological and psychosocial determinants, epilepsy-related variables (age at onset of seizures, temporal lobe epilepsy and frequency of seizures) and the antiepileptic drug treatment have been associated with depression. Nonetheless, data on treatment strategies are still limited with a lack of controlled trials on the use of antidepressant drugs. Moreover, the issue of psychotropic drug treatment of depression in epilepsy is interlinked with that of worsening seizures. This paper is aimed at discussing all these subjects in the light of current literature on the neurobiology of depression in epilepsy.

Entities:  

Keywords:  antidepressant drugs; antiepileptic drugs; depression; epilepsy

Year:  2009        PMID: 21180624      PMCID: PMC3002598          DOI: 10.1177/1756285609337340

Source DB:  PubMed          Journal:  Ther Adv Neurol Disord        ISSN: 1756-2856            Impact factor:   6.570


  57 in total

1.  Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.

Authors:  Madhukar H Trivedi; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Diane Warden; Louise Ritz; Grayson Norquist; Robert H Howland; Barry Lebowitz; Patrick J McGrath; Kathy Shores-Wilson; Melanie M Biggs; G K Balasubramani; Maurizio Fava
Journal:  Am J Psychiatry       Date:  2006-01       Impact factor: 18.112

2.  Patient-validated content of epilepsy-specific quality-of-life measurement.

Authors:  F Gilliam; R Kuzniecky; E Faught; L Black; G Carpenter; R Schrodt
Journal:  Epilepsia       Date:  1997-02       Impact factor: 5.864

3.  Sertraline and fluoxetine: safe treatments for children and adolescents with epilepsy and depression.

Authors:  M S Thomé-Souza; E Kuczynski; K D Valente
Journal:  Epilepsy Behav       Date:  2007-02-15       Impact factor: 2.937

4.  Depression in patients with temporal lobe epilepsy is related to mesial temporal sclerosis.

Authors:  A Quiske; C Helmstaedter; S Lux; C E Elger
Journal:  Epilepsy Res       Date:  2000-04       Impact factor: 3.045

5.  Depression in complex partial seizures. Electroencephalography and cerebral metabolic correlates.

Authors:  J I Victoroff; F Benson; S T Grafton; J Engel; J C Mazziotta
Journal:  Arch Neurol       Date:  1994-02

6.  Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study.

Authors:  S Y Tan; J Bruni
Journal:  Epilepsia       Date:  1986 May-Jun       Impact factor: 5.864

7.  Psychiatric comorbidity in epilepsy: a population-based analysis.

Authors:  Jose F Tellez-Zenteno; Scott B Patten; Nathalie Jetté; Jeanne Williams; Samuel Wiebe
Journal:  Epilepsia       Date:  2007-07-28       Impact factor: 5.864

8.  The clinical course of epilepsy and its psychosocial correlates: findings from a U.K. Community study.

Authors:  A Jacoby; G A Baker; N Steen; P Potts; D W Chadwick
Journal:  Epilepsia       Date:  1996-02       Impact factor: 5.864

9.  Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants.

Authors:  Kai Uwe Kühn; Boris B Quednow; Markus Thiel; Peter Falkai; Wolfgang Maier; Christian E Elger
Journal:  Epilepsy Behav       Date:  2003-12       Impact factor: 2.937

10.  The influence of comorbid depression on quality of life for people with epilepsy.

Authors:  Joyce A Cramer; David Blum; Michael Reed; Kristina Fanning
Journal:  Epilepsy Behav       Date:  2003-10       Impact factor: 2.937

View more
  14 in total

1.  High Rates of Genetic Diagnosis in Psychiatric Patients with and without Neurodevelopmental Disorders: Toward Improved Genetic Diagnosis in Psychiatric Populations.

Authors:  Joyce So; Venuja Sriretnakumar; Jessica Suddaby; Brianna Barsanti-Innes; Hanna Faghfoury; Timothy Gofine
Journal:  Can J Psychiatry       Date:  2020-06-04       Impact factor: 4.356

Review 2.  [Coexistent depressive and anxiety disorders in epilepsy and multiple sclerosis: a challenge to neuropsychiatric practice].

Authors:  Hans-Peter Kapfhammer
Journal:  Neuropsychiatr       Date:  2014-05-20

3.  [Psychiatric aspects of epileptic disorders].

Authors:  B Schmitz
Journal:  Nervenarzt       Date:  2012-02       Impact factor: 1.214

Review 4.  Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?

Authors:  L Cardamone; M R Salzberg; T J O'Brien; N C Jones
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

Review 5.  Antidepressants for people with epilepsy and depression.

Authors:  Melissa J Maguire; Jennifer Weston; Jasvinder Singh; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2014-12-03

Review 6.  Adverse events of placebo-treated, drug-resistant, focal epileptic patients in randomized controlled trials: a systematic review.

Authors:  Gaetano Zaccara; Fabio Giovannelli; Massimo Cincotta; Giulia Loiacono; Alberto Verrotti
Journal:  J Neurol       Date:  2014-06-11       Impact factor: 4.849

7.  Antidepressants for people with epilepsy and depression.

Authors:  Melissa J Maguire; Anthony G Marson; Sarah J Nevitt
Journal:  Cochrane Database Syst Rev       Date:  2021-04-16

8.  What is Depression in Epilepsy?

Authors:  Christian E Elger; Christian Hoppe
Journal:  Front Neurol       Date:  2011-12-07       Impact factor: 4.003

Review 9.  The effects of herbal medicine on epilepsy.

Authors:  Wei Liu; Tongtong Ge; Zhenxiang Pan; Yashu Leng; Jiayin Lv; Bingjin Li
Journal:  Oncotarget       Date:  2017-07-18

10.  Depression in temporal lobe epilepsy: a review of prevalence, clinical features, and management considerations.

Authors:  C S Garcia
Journal:  Epilepsy Res Treat       Date:  2011-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.